A large insurance company has decided to no longer cover laparoscopic power morcellation. Is this the beginning of the end of power morcellators?
The best-ranked hospitals for gynecology have once again been listed by U.S. News & World Report. We noticed a trend—observational only—and want to know what you think.
The morcellation controversy heats up as physicians all over the world who use Ethicon power morcellators are being asked to return the medical devices.
Gyns morcellate fibroids because it benefits patients, not their wallet. Despite the risks, the procedure has a place in treatment, until data say otherwise.
Vaginal hysterectomies are associated with superior patient outcomes and cost less than other methods of hysterectomy. So why is their rate of use declining?
The FDA has weighed in on the safety of uterine fibroid morcellation. Given the current evidence, find out what they recommend.
Patients with uterine fibroids have been advised to avoid a hysterectomy as treatment of the condition at all costs. Sound advice or mucky water?
Evidence indicates that angiogenic growth factors have an important role in fibroid pathophysiology, including abnormal vasculature and fibroid growth and survival.
Robotic-assisted laparoscopic myomectomy and abdominal myomectomy to manage uterine fibroids were equally effective in improving symptoms, but each procedure has its own benefits.
Compared with hysterectomy, GNRHa is an effective treatment of uterine fibroids and has an equivalent effect on sexual function.